These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12821298)

  • 1. Challenges in molecular analysis for individualized cancer therapy.
    Clynes M; O'Connor R; O'Driscoll L; Daly C; Meleady P
    Drug Discov Today; 2003 Jun; 8(12):531. PubMed ID: 12821298
    [No Abstract]   [Full Text] [Related]  

  • 2. Using microarrays to predict resistance to chemotherapy in cancer patients.
    Lee CH; Macgregor PF
    Pharmacogenomics; 2004 Sep; 5(6):611-25. PubMed ID: 15335284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic alterations and chemoresistance].
    Akiyama S
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1895-901. PubMed ID: 16282723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor mRNA expression profiles predict responses to chemotherapy.
    Minna JD; Girard L; Xie Y
    J Clin Oncol; 2007 Oct; 25(28):4329-36. PubMed ID: 17906194
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapy: overcoming drug resistance with clinical cancer genome.
    Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach.
    Huang Y; Sadée W
    Drug Discov Today; 2003 Apr; 8(8):356-63. PubMed ID: 12681939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics technique predicts chemotherapy success.
    Traynor K
    Am J Health Syst Pharm; 2006 Dec; 63(23):2304-6. PubMed ID: 17105999
    [No Abstract]   [Full Text] [Related]  

  • 9. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
    Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
    Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic profiling can predict chemotherapy side effects and treatment response.
    Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in gene expression profiles and carcinogenesis pathways involved in cisplatin resistance of four types of cancer.
    Yang Y; Li H; Hou S; Hu B; Liu J; Wang J
    Oncol Rep; 2013 Aug; 30(2):596-614. PubMed ID: 23733047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CINSARC signature: prognostic and predictive of response to chemotherapy?
    Bertucci F; Finetti P; Sabatier R; Birnbaum D
    Cell Cycle; 2010 Oct; 9(19):4025-7. PubMed ID: 20978372
    [No Abstract]   [Full Text] [Related]  

  • 13. DualChip microarray as a new tool in cancer research.
    Gillet JP; de Longueville F; Remacle J
    Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From correlation to causality: microarrays, cancer, and cancer treatment.
    O'Neill GM; Catchpoole DR; Golemis EA
    Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genome analysis and cancer therapy].
    Tahara H
    Nihon Geka Gakkai Zasshi; 2005 Nov; 106(11):706-9. PubMed ID: 16304819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preface: National Cancer Act.
    Smalley KS
    Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA-based therapy unlocks drugs within cancer cells.
    Erdmann J
    J Natl Cancer Inst; 2002 Dec; 94(24):1829-30. PubMed ID: 12488474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Exploitation of expression profiles: examples in oncology].
    Galiègue S; Casellas P
    J Soc Biol; 2002; 196(4):313-5. PubMed ID: 12645302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of treatment resistance: hype or hope for therapeutic target identification.
    Helleman J; Jansen MP; Berns EM
    Int J Gynecol Cancer; 2006; 16 Suppl 2():538-42. PubMed ID: 17010068
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.